RPID (Rapid Micro Biosystems) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RPID Rapid Micro Biosystems Inc RPID
59 GF Score
Price $2.07
GF Value $1.89
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Rapid Micro Biosystems Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

RPID
59GF Score
Rapid Micro Biosystems Inc RPID
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Rapid Micro Biosystems (RPID) Overvalued in 2026?

Based on GuruFocus' analysis, Rapid Micro Biosystems stock appears to be overvalued. The current stock price of $2.07 is trading 9.5% above its estimated GF Value™ of $1.89. GuruFocus considers Rapid Micro Biosystems to be Modestly Overvalued.

Key valuation signals for RPID:

  • Dividends Received:
  • GF Value™: $1.89 vs. price of $2.07 (9.5% above fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the RPID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rapid Micro Biosystems Business Description

Address 25 Hartwell Avenue, Lexington, MA, USA, 02421
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
59GF Score

Get the complete analysis for RPID

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.07
Price
$1.89
GF Value